|
|
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Report of the Director and |
|
Financial Statements for the Year Ended 31 December 2016 |
|
for |
|
IBA Molecular UK Limited |
|
|
REGISTERED NUMBER:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Report of the Director and |
|
Financial Statements for the Year Ended 31 December 2016 |
|
for |
|
IBA Molecular UK Limited |
IBA Molecular UK Limited (Registered number: 04794962) |
|
|
|
|
|
|
Contents of the Financial Statements |
for the Year Ended 31 December 2016 |
|
|
|
|
Page |
|
Company Information | 1 |
|
Report of the Director | 2 |
|
Report of the Independent Auditors | 3 |
|
Income Statement | 5 |
|
Balance Sheet | 6 |
|
Notes to the Financial Statements | 7 |
|
IBA Molecular UK Limited |
|
Company Information |
for the Year Ended 31 December 2016 |
|
|
|
|
|
|
|
DIRECTOR: |
|
|
|
|
|
|
SECRETARY: |
|
|
|
|
|
|
REGISTERED OFFICE: |
|
|
|
|
|
|
|
|
|
|
REGISTERED NUMBER: |
|
|
|
|
|
|
AUDITORS: |
|
and Chartered Accountants |
Elm House, Tanshire Park |
Shackleford Road, Elstead |
Godalming |
Surrey |
GU8 6LB |
IBA Molecular UK Limited (Registered number: 04794962) |
|
Report of the Director |
for the Year Ended 31 December 2016 |
|
The director presents her report with the financial statements of the company for the year ended 31 December 2016. |
|
DIRECTORS |
The directors who have held office during the period from 1 January 2016 to the date of this report are as follows: |
|
|
|
|
STATEMENT OF DIRECTOR'S RESPONSIBILITIES |
The director is responsible for preparing the Report of the Director and the financial statements in accordance with |
applicable law and regulations. |
|
Company law requires the director to prepare financial statements for each financial year. Under that law the director |
has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting |
Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve |
the financial statements unless she is satisfied that they give a true and fair view of the state of affairs of the company |
and of the profit or loss of the company for that period. In preparing these financial statements, the director is required |
to: |
|
- | select suitable accounting policies and then apply them consistently; |
- | make judgements and accounting estimates that are reasonable and prudent; |
|
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the |
company's transactions and disclose with reasonable accuracy at any time the financial position of the company and |
enable her to ensure that the financial statements comply with the Companies Act 2006. She is also responsible for |
safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud |
and other irregularities. |
|
STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act |
2006) of which the company's auditors are unaware, and she has taken all the steps that she ought to have taken as a |
director in order to make herself aware of any relevant audit information and to establish that the company's auditors are |
aware of that information. |
|
AUDITORS |
The auditors, Chamberlains Statutory Auditors, will be proposed for re-appointment at the forthcoming Annual General |
Meeting. |
|
This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small |
companies. |
|
ON BEHALF OF THE BOARD: |
|
|
|
|
|
|
|
|
|
Report of the Independent Auditors to the Members of |
IBA Molecular UK Limited |
|
We have audited the financial statements of IBA Molecular UK Limited for the year ended 31 December 2016 on pages |
five to eight. The financial reporting framework that has been applied in their preparation is applicable law and United |
Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial |
Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. |
|
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the |
Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those |
matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent |
permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's |
members as a body, for our audit work, for this report, or for the opinions we have formed. |
|
Respective responsibilities of director and auditors |
|
|
Scope of the audit of the financial statements |
An audit involves obtaining evidence about the amounts and disclosures in the financial statements sufficient to give |
reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or error. |
This includes an assessment of: whether the accounting policies are appropriate to the company's circumstances and |
have been consistently applied and adequately disclosed; the reasonableness of significant accounting estimates made by |
the director; and the overall presentation of the financial statements. In addition, we read all the financial and |
non-financial information in the Report of the Director to identify material inconsistencies with the audited financial |
statements and to identify any information that is apparently materially incorrect based on, or materially inconsistent |
with, the knowledge acquired by us in the course of performing the audit. If we become aware of any apparent material |
misstatements or inconsistencies we consider the implications for our report. |
|
|
Opinion on financial statements |
In our opinion the financial statements: |
- |
give a true and fair view of the state of the company's affairs as at 31 December 2016 and of its profit for the year
then ended; |
- | have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and |
- | have been prepared in accordance with the requirements of the Companies Act 2006. |
|
Emphasis of matter |
As set out in note 3, there is uncertainty as to the liability to Corporation Tax that might arise on the results for the year, |
but in the opinion of the Directors it is more likely than not that any liability will arise. |
|
Opinion on other matter prescribed by the Companies Act 2006 |
In our opinion, based on the work undertaken in the course of our audit, the information given in the Report of the |
Director for the financial year for which the financial statements are prepared is consistent with the financial statements, |
and has been prepared in accordance with applicable legal requirements. In the light of the knowledge and understanding |
of the company and its environment, we have not identified any material misstatements in the Report of the Director. |
Report of the Independent Auditors to the Members of |
IBA Molecular UK Limited |
|
|
Matters on which we are required to report by exception |
We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you |
if, in our opinion: |
- |
adequate accounting records have not been kept, or returns adequate for our audit have not been received from
branches not visited by us; or |
- | the financial statements are not in agreement with the accounting records and returns; or |
- | certain disclosures of director's remuneration specified by law are not made; or |
- | we have not received all the information and explanations we require for our audit; or |
- |
the director was not entitled to prepare the financial statements in accordance with the small companies regime and
take advantage of the small companies' exemption from the requirement to prepare a Strategic Report or in preparing the Report of the Director. |
|
|
|
|
|
for and on behalf of
|
and Chartered Accountants |
Elm House, Tanshire Park |
Shackleford Road, Elstead |
Godalming |
Surrey |
GU8 6LB |
|
|
IBA Molecular UK Limited (Registered number: 04794962) |
|
Income Statement |
for the Year Ended 31 December 2016 |
|
31.12.16 | 31.12.15 |
Notes | £ | £ |
|
TURNOVER |
|
|
|
Cost of sales |
|
( |
) |
GROSS PROFIT |
|
|
|
Administrative expenses | ( |
) |
|
OPERATING PROFIT/(LOSS) |
|
( |
) |
|
Interest receivable and similar income |
|
|
PROFIT/(LOSS) BEFORE TAXATION |
|
( |
) |
|
Tax on profit/(loss) |
|
|
PROFIT/(LOSS) FOR THE FINANCIAL
YEAR |
|
( |
) |
IBA Molecular UK Limited (Registered number: 04794962) |
|
Balance Sheet |
31 December 2016 |
|
31.12.16 | 31.12.15 |
Notes | £ | £ |
CURRENT ASSETS |
Debtors | 4 |
|
|
Cash in hand |
|
|
|
|
CREDITORS |
Amounts falling due within one year | 5 |
|
|
NET CURRENT ASSETS |
|
|
TOTAL ASSETS LESS CURRENT
LIABILITIES |
|
|
|
PROVISIONS FOR LIABILITIES |
|
|
NET ASSETS |
|
|
|
CAPITAL AND RESERVES |
Called up share capital | 7 |
|
|
Retained earnings |
( |
) |
( |
) |
SHAREHOLDERS' FUNDS |
|
|
|
|
|
The financial statements were approved by the director on
|
|
|
|
|
|
|
|
IBA Molecular UK Limited (Registered number: 04794962) |
|
Notes to the Financial Statements |
for the Year Ended 31 December 2016 |
|
1. | STATUTORY INFORMATION |
|
IBA Molecular UK Limited is a
|
company's registered number and registered office address can be found on the Company Information page. |
|
2. | ACCOUNTING POLICIES |
|
Basis of preparing the financial statements |
|
|
Turnover |
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, |
value added tax and other sales taxes. |
|
Taxation |
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to |
the extent that it relates to items recognised in other comprehensive income or directly in equity. |
|
Current or deferred taxation assets and liabilities are not discounted. |
|
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or |
substantively enacted by the balance sheet date. |
|
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance |
sheet date. |
|
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from |
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that |
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the |
timing difference. |
|
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they |
will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
|
Foreign currencies |
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the |
balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at |
the date of transaction. Exchange differences are taken into account in arriving at the operating result. |
|
Decommissioning provision |
A decommissioning provision is recognised when a site is constructed to provide for the expected costs payable |
to decommission it in accordance with the lease agreements and local regulatory requirements. |
|
The provisions are calculated by management with reference to the work of external experts in the field and are |
discounted to reflect the time value of money where this is material. See note 7. |
|
Debtors and creditors receivable/payable within one year |
Debtors and creditors with no stated interest rate or payable within one year are recorded at transaction value. |
Losses arising from impairment are recognised in the profit and loss account. |
IBA Molecular UK Limited (Registered number: 04794962) |
|
Notes to the Financial Statements - continued |
for the Year Ended 31 December 2016 |
|
3. | CORPORATION TAX |
|
In the year under review the company made a trading profit, but no Corporation Tax liability arises due to the |
availability of losses brought forward. The company also made a gain on a non-trading loan relationship. Losses |
on non-trading loan relationships brought forward do not entirely offset this gain for Corporation Tax purposes |
and consequently it is possible that a Corporation tax liability might arise. No provision for this liability has been |
made as the Directors are of the opinion that it is more likely than not that no Corporation Tax liability will arise |
due to the availability of losses elsewhere in the group. If a Corporation Tax liability does arise the Directors |
estimate that the liability will amount to £36,781. |
|
4. | DEBTORS |
31.12.16 | 31.12.15 |
£ | £ |
Amounts falling due within one year: |
Trade debtors |
|
|
Other debtors |
|
|
|
|
|
Amounts falling due after more than one year: |
Other debtors |
|
|
|
Aggregate amounts |
|
|
|
5. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
31.12.16 | 31.12.15 |
£ | £ |
Trade creditors |
|
|
Other creditors |
|
|
|
|
|
6. | LEASING AGREEMENTS |
Total financial commitments, relating to operating leases expiring in more than five years, which are not included |
in the balance sheet amounted to £2,065,851 (2015: £2,080,347). |
|
7. | CALLED UP SHARE CAPITAL |
|
|
Allotted, issued and fully paid: |
Number: | Class: | Nominal | 31.12.16 | 31.12.15 |
value: | £ | £ |
|
Ordinary | 1 | 23,173,157 | 23,173,157 |
|
8. | RELATED PARTY DISCLOSURES |
|
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The |
Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party |
transactions with wholly owned subsidiaries within the group. |